A Phase 2, Double-Blinded, Randomized, Placebo-Controlled, Dose-Escalation Study to Examine the Safety, Tolerability, Pharmacokinetics and Antiviral Activity of ISIS 505358 in Treatment-Naïve Patients With Chronic HBV Infection
收藏DataCite Commons2025-05-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007561/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
To examine the safety and tolerability of IONIS-HBVRx administration to treatment-naive
patients with chronic hepatitis B virus infection
提供机构：
Vivli
创建时间：
2021-12-21
